Financial results - NATISAN MEDICINA GENERALA SRL

Financial Summary - Natisan Medicina Generala Srl
Unique identification code: 15450062
Registration number: J03/659/2003
Nace: 8621
Sales - Ron
3.056.387
Net Profit - Ron
353.622
Employees
36
Open Account
Company Natisan Medicina Generala Srl with Fiscal Code 15450062 recorded a turnover of 2024 of 3.056.387, with a net profit of 353.622 and having an average number of employees of 36. The company operates in the field of Activităţi de asistenţă medicală generală having the NACE code 8621.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Natisan Medicina Generala Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 1.078.420 1.291.991 1.480.823 1.333.769 1.471.698 1.655.604 1.621.729 1.817.307 2.846.082 3.056.387
Total Income - EUR 1.092.382 1.314.417 1.480.837 1.333.910 1.673.992 1.937.067 1.727.505 1.948.986 2.884.390 3.171.566
Total Expenses - EUR 749.963 970.233 1.073.213 1.153.610 1.444.964 1.468.010 1.557.557 1.702.498 2.523.218 2.758.439
Gross Profit/Loss - EUR 342.418 344.184 407.624 180.300 229.029 469.057 169.948 246.488 361.172 413.127
Net Profit/Loss - EUR 297.178 303.265 361.314 151.446 192.269 408.129 143.528 214.162 313.108 353.622
Employees 52 44 44 47 39 40 38 35 36 36
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 8.0%, from 2.846.082 euro in the year 2023, to 3.056.387 euro in 2024. The Net Profit increased by 42.263 euro, from 313.108 euro in 2023, to 353.622 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Natisan Medicina Generala Srl

Rating financiar

Financial Rating -
NATISAN MEDICINA GENERALA SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Natisan Medicina Generala Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Natisan Medicina Generala Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Natisan Medicina Generala Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Natisan Medicina Generala Srl - CUI 15450062

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 460.883 656.026 665.504 537.766 1.412.282 1.090.175 855.425 1.013.301 1.640.407 1.313.933
Current Assets 453.452 287.279 427.967 567.526 423.009 719.707 960.366 1.231.405 1.148.583 597.948
Inventories 389 0 4.214 13.951 0 7.549 7.134 543.783 0 0
Receivables 139.299 131.893 166.045 158.067 270.345 235.490 758.843 361.243 546.156 232.554
Cash 313.764 155.386 257.708 395.507 152.664 476.668 194.389 326.379 602.427 365.394
Shareholders Funds 683.306 545.387 762.762 854.970 915.359 1.134.304 1.193.682 861.375 1.125.717 939.494
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 212.546 379.623 312.724 232.667 902.620 547.603 574.970 1.336.869 1.641.974 951.206
Income in Advance 0 0 0 0 0 105.058 25.841 25.098 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8621 - 8621"
CAEN Financial Year 8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 597.948 euro in 2024 which includes Inventories of 0 euro, Receivables of 232.554 euro and cash availability of 365.394 euro.
The company's Equity was valued at 939.494 euro, while total Liabilities amounted to 951.206 euro. Equity decreased by -179.931 euro, from 1.125.717 euro in 2023, to 939.494 in 2024.

Risk Reports Prices

Reviews - Natisan Medicina Generala Srl

Comments - Natisan Medicina Generala Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.